XML 42 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Based Awards (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity Option activity under the plan for the year to date period ending March 31, 2024 is as follows:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price
(Per
Share)

 

 

Weighted-
Average
Remaining
Contractual
Life
(in years)

 

Outstanding at December 31, 2023

 

 

10,888,451

 

 

$

2.07

 

 

 

6.13

 

Granted

 

 

—

 

 

 

—

 

 

 

 

Exercised

 

 

—

 

 

 

—

 

 

 

 

Forfeited

 

 

(131,876

)

 

 

1.81

 

 

 

 

Outstanding at March 31, 2024

 

 

10,756,575

 

 

$

2.07

 

 

5.89

 

Options exercisable at March 31, 2024

 

 

10,117,051

 

 

$

2.07

 

 

 

5.84

 

Summary of Additional information Regarding Exercise of Stock Options

Additional information regarding the exercise of stock options is as follows:

 

 

 

Three Months Ended March 31,

(in thousands, except weighted average)

 

2024

 

 

2023

Intrinsic value of options exercised

 

 

—

 

 

493

Summary of Restricted Stock Units Activity The following table summarizes the RSU activity for the three months ended March 31, 2024:

 

 

 

Number of
Shares

 

 

Weighted-
Average
Grant Date Fair Value
(Per
Share)

 

Outstanding at December 31, 2023

 

 

15,310,998

 

 

$

2.12

 

Granted

 

 

99,800

 

 

 

0.66

 

Vested

 

 

(989,304

)

 

 

2.72

 

Forfeited

 

 

(703,589

)

 

 

1.92

 

Unvested at March 31, 2024

 

 

13,717,905

 

 

$

2.08

 

Summary of Recognized Stock-based Compensation Expense

 

 

Three Months Ended March 31,

 

(in thousands)

 

2024

 

 

2023

 

Stock options

 

$

299

 

 

$

738

 

Restricted stock units

 

 

3,199

 

 

 

3,406

 

Stock-based compensation expense for restricted stock units and options

 

$

3,498

 

 

$

4,144

 

Summary Of Stock-based Compensation Based On Awards Granted

The stock-based compensation expense for stock-based awards and earnout shares were recognized in the following captions within the condensed consolidated statements of operations for the three months ended March 31, 2024 and 2023:

 

 

 

Three Months Ended March 31,

 

(in thousands)

 

2024

 

 

2023

 

Cost of revenue

 

$

49

 

 

$

73

 

Sales and marketing

 

 

405

 

 

 

475

 

Research and development

 

 

1,100

 

 

 

1,147

 

General and administrative

 

 

1,907

 

 

 

2,661

 

Total stock-based compensation expense

 

$

3,461

 

 

$

4,356